This compound is a Fmoc-protected amino acid derivative used in solid-phase peptide synthesis. It features a penicillamine backbone with an S-acetamidomethyl protecting group, enabling selective deprotection strategies in research-scale peptide manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 201531-76-2
N-{[(9H-Fluoren-9-yl)methoxy]carbonyl}-L-alanine--water (1/1)
pharmaceutical intermediate
Fmoc-Glycine
pharmaceutical intermediate
N-Fmoc-L-Asparagine
pharmaceutical intermediate
Fmoc-L-Methionine
pharmaceutical intermediate
Fmoc-S-Trityl-L-penicillamine
pharmaceutical intermediate
Diethyl dichloromalonate
pharmaceutical intermediate
N-Acetyl-S-(2-carboxyethyl)-L-cysteine Bis(dicyclohexylamine) Salt
pharmaceutical intermediate
(R)-N-(2-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)phenyl)formamide
pharmaceutical intermediate
(2R)-3-(acetamidomethylsulfanyl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methylbutanoic acid
HJXCJYNKTHOYRD-HXUWFJFHSA-N
CC(=O)NCSC(C)(C)[C@@H](C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13